Coric Vlad, Chief Executive Officer, made open market purchases of Veradermics Inc ($MANE) shares twice in the last 365 days for nearly $2 million, with the most recent on February 5, 2026. These rank 321st among nearly 5,000 insiders. He also bought Biohaven Ltd ($BHVN) shares twice for $5 million, most recently on November 13, 2025, ranking 175th. His activity exceeds the average insider purchase of $1.5 million across 3.3 transactions. Vlad reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | A | Stock Options (Right to buy) | 550000 | $0.00 | 550,000.0000 | 105,855,155 | 9999.99% | 0.52% |
| Feb. 3, 2026 | Veradermics, Inc | $MANE | Coric Vlad | Director | A | Stock Option (Right to Buy) | 51525 | $0.00 | 51,525.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2026 | Veradermics, Inc | $MANE | Coric Vlad | Director | C | Series C Convertible Preferred Stock | 117112 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 5, 2026 | Veradermics, Inc | $MANE | Coric Vlad | Director | C | Series C Convertible Preferred Stock | 78075 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 5, 2026 | Veradermics, Inc | $MANE | Coric Vlad | Director | C | Series C Convertible Preferred Stock | 78075 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 5, 2026 | Veradermics, Inc | $MANE | Coric Vlad | Director | C | Series B Convertible Preferred Stock | 148794 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 5, 2026 | Veradermics, Inc | $MANE | Coric Vlad | Director | C | Series B Convertible Preferred Stock | 148794 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 5, 2026 | Veradermics, Inc | $MANE | Coric Vlad | Director | C | Series A Convertible Preferred Stock | 33706 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 5, 2026 | Veradermics, Inc | $MANE | Coric Vlad | Director | C | Series A Convertible Preferred Stock | 33706 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 5, 2026 | Veradermics, Inc | $MANE | Coric Vlad | Director | P | Common Stock | 58823 | $17.00 | 449,337.0000 | 0 | 15.06% | 0.00% |
| Feb. 5, 2026 | Veradermics, Inc | $MANE | Coric Vlad | Director | P | Common Stock | 58823 | $17.00 | 449,337.0000 | 0 | 15.06% | 0.00% |
| Feb. 5, 2026 | Veradermics, Inc | $MANE | Coric Vlad | Director | C | Common Stock | 117112 | $0.00 | 449,337.0000 | 0 | 35.25% | 0.00% |
| Feb. 5, 2026 | Veradermics, Inc | $MANE | Coric Vlad | Director | C | Common Stock | 78075 | $0.00 | 390,514.0000 | 0 | 24.99% | 0.00% |
| Feb. 5, 2026 | Veradermics, Inc | $MANE | Coric Vlad | Director | C | Common Stock | 78075 | $0.00 | 390,514.0000 | 0 | 24.99% | 0.00% |
| Feb. 5, 2026 | Veradermics, Inc | $MANE | Coric Vlad | Director | C | Common Stock | 148794 | $0.00 | 312,439.0000 | 0 | 90.92% | 0.00% |
| Feb. 5, 2026 | Veradermics, Inc | $MANE | Coric Vlad | Director | C | Common Stock | 148794 | $0.00 | 312,439.0000 | 0 | 90.92% | 0.00% |
| Feb. 5, 2026 | Veradermics, Inc | $MANE | Coric Vlad | Director | C | Common Stock | 33706 | $0.00 | 163,645.0000 | 0 | 25.94% | 0.00% |
| Feb. 5, 2026 | Veradermics, Inc | $MANE | Coric Vlad | Director | C | Common Stock | 33706 | $0.00 | 163,645.0000 | 0 | 25.94% | 0.00% |
| Jan. 5, 2026 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | F | Common Shares | 7430 | $9.93 | 3,849,354.0000 | 105,855,155 | 0.19% | 0.01% |
| Jan. 5, 2026 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | M | Restricted Share Unit Award | 14250 | $0.00 | 28,500.0000 | 105,855,155 | 33.33% | 0.01% |
| Jan. 5, 2026 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | M | Common Shares | 14250 | $0.00 | 3,856,784.0000 | 105,855,155 | 0.37% | 0.01% |
| Nov. 13, 2025 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | P | Common Shares | 333333 | $7.50 | 3,842,534.0000 | 105,855,155 | 9.50% | 0.31% |
| Nov. 13, 2025 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | P | Common Shares | 333333 | $7.50 | 3,842,534.0000 | 105,855,155 | 9.50% | 0.31% |
| May 13, 2025 | Royalty Pharma plc | $RPRX | Coric Vlad | Director | A | Class A Ordinary Shares | 7614 | $0.00 | 10,798.0000 | 594,108,000 | 239.13% | 0.00% |
| April 21, 2025 | Royalty Pharma plc | $RPRX | Coric Vlad | Director | A | Class A Ordinary Shares | 3184 | $0.00 | 3,184.0000 | 594,108,000 | 9999.99% | 0.00% |
| Jan. 5, 2025 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | A | Stock Options (Right to buy) | 343000 | $0.00 | 343,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2025 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | M | Common Shares | 14250 | $0.00 | 3,182,129.0000 | 0 | 0.45% | 0.00% |
| Jan. 5, 2025 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | A | Restricted Share Unit Award | 57000 | $0.00 | 57,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2025 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | M | Restricted Share Unit Award | 14250 | $0.00 | 42,750.0000 | 0 | 25.00% | 0.00% |
| Jan. 5, 2025 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | F | Common Shares | 6805 | $38.64 | 3,175,324.0000 | 0 | 0.21% | 0.00% |
| Oct. 2, 2024 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | P | Common Shares | 21052 | $47.50 | 3,167,879.0000 | 0 | 0.67% | 0.00% |
| April 22, 2024 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | P | Common Shares | 121951 | $41.00 | 3,146,085.0000 | 0 | 4.03% | 0.00% |
| April 5, 2024 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | A | Common Shares | 232 | $0.00 | 3,024,134.0000 | 0 | 0.01% | 0.00% |
| April 5, 2024 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | A | Common Shares | 231 | $0.00 | 3,024,134.0000 | 0 | 0.01% | 0.00% |
| April 5, 2024 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | A | Common Shares | 231 | $0.00 | 3,024,134.0000 | 0 | 0.01% | 0.00% |
| March 8, 2024 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | A | Common Shares | 2155 | $0.00 | 3,023,440.0000 | 0 | 0.07% | 0.00% |
| March 8, 2024 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | A | Common Shares | 2155 | $0.00 | 3,023,440.0000 | 0 | 0.07% | 0.00% |
| March 8, 2024 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | A | Common Shares | 2162 | $0.00 | 3,023,440.0000 | 0 | 0.07% | 0.00% |
| Jan. 8, 2024 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | A | Common Shares | 5384 | $0.00 | 3,015,327.0000 | 0 | 0.18% | 0.00% |
| Jan. 8, 2024 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | A | Common Shares | 5400 | $0.00 | 3,015,327.0000 | 0 | 0.18% | 0.00% |
| Jan. 8, 2024 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | A | Common Shares | 5384 | $0.00 | 3,015,327.0000 | 0 | 0.18% | 0.00% |
| Jan. 2, 2024 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | A | Stock Options (Right to buy) | 275000 | $0.00 | 275,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 2, 2023 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | A | Stock Options (Right to buy) | 225000 | $0.00 | 225,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 5, 2023 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | P | Common Shares | 113637 | $22.00 | 2,166,039.0000 | 0 | 5.54% | 0.00% |
| Oct. 5, 2023 | Biohaven Ltd. | $BHVN | Coric Vlad | Chief Executive Officer | P | Common Share | 340908 | $22.00 | 833,120.0000 | 0 | 69.26% | 0.00% |